Home Tools
Log in
Cart

Search Result

Search Results for " tg02 "

7

Compounds

Cat No. Product Name Synonyms Targets
T21503 (E/Z)-Zotiraciclib (E/Z)-TG02,(E/Z)-SB1317 FLT , JAK , CDK
(E/Z)-Zotiraciclib ((E/Z)-TG02) inhibits CDK2, JAK2, and FLT3 effectively with IC50s of 13, 73, and 56 nM, respectively.
T2653 SB1317 TG02 FLT , JAK , CDK
SB1317 (TG02) is a potent inhibitor of cyclin dependant kinases (CDKs), Janus kinase 2 (JAK2), and Fms-like tyrosine kinase-3 (FLT3).
T70895 H 35-25
H 35-25 is a beta 2-antagonist.
T4227 SB1317 hydrochloride (1204918-72-8(free base)) TG-02 hydrochloride FLT , JAK , CDK
SB1317 hydrochloride (1204918-72-8(free base)) (TG-02 hydrochloride) is an effective inhibitor of CDK2/JAK2/FLT3 (IC50: 13/73/56 nM).
T62056 (E/Z)-Zotiraciclib hydrochloride
(E/Z)-Zotiraciclib ((E/Z)-TG02) hydrochloride is a potent inhibitor of CDK2, JAK2, and FLT3.
T63998 (E/Z)-Zotiraciclib citrate
(E/Z)-Zotiraciclib ((E/Z)-TG02) citrate is a potent inhibitor of CDK2, JAK2 and FLT3 and can be used in cancer research.
T70897 Zotiraciclib HCl
Zotiraciclib, also known as TG02 and SB1317, is a novel small molecule potent CDK/JAK2/FLT3 inhibitor. Zotiraciclib may be useful for the treatment of cancer that crosses the blood brain barrier and acts by depleting M...
TargetMol